“One of the most commonly prescribed antihypertensives, HCTZ is associated with rare cases of pulmonary edema, which typically develop within minutes to hours of the initial dose of the medication,” the study authors stated.
To date, there have been no reports of any adverse events related to this recall.
According to the authors, this is the first study to identify medications most commonly reported for a specific adverse reaction using this database.
First FDA-approved oral liquid dosage form of the potassium-sparing diuretic spironolactone.
The lowest effective dose for the shortest duration possible should be used to minimize the potential risk.
Par Pharmaceuticals announced that the Food and Drug Administration (FDA) has approved Ethacrynate Sodium for Injection, the first generic version of Aton Pharma’s Sodium Edecrin.
Unichem Pharmaceuticals issued a voluntary nationwide recall of Hydrochlorothiazide 25mg tablets after the discovery of a Clopidogrel tablet in a bottle.
One of three survey respondents rejected the idea even if it meant a shorter life
Taking spironolactone alongside the antibiotic trimethoprim-sulfamethoxazole can cause blood potassium to rise to potentially life-threatening levels.
Research indicates that spironolactone may reduce rehospitalizations and 30-day mortality in patients with acute heart failure (AHF).
